Fortrea Holdings Inc.

About Fortrea Holdings Inc.

Fortrea is a global contract research organization spun out from LabCorp in 2023 to provide drug development services across Phases I-IV. It offers clinical trial management, patient access solutions, regulatory consulting, and commercialization support to biopharmaceutical, medical device, and diagnostic clients. The company operates in more than 90 countries with 19,000 employees, leveraging therapeutic expertise in oncology, rare diseases, neuroscience, and other complex areas to accelerate therapies from lab to market while prioritizing patient experience and data-driven insights.